Comparison of alterations of the stomatognathic system in critical patients with and without covid-19 diagnosis
DOI:
https://doi.org/10.51723/hrj.v6i32.768Keywords:
Oral pathologies, Critical patient, Intensive care, Oral health, Covid-19Abstract
Objective: the oral cavity is susceptible to the development of pathologies that are related to the situation of imbalance in the state of homeostasis experienced by the critical patient. It is necessary to identify which alterations these patients are more likely to develop, in order to understand their impact on systemic health, prevent their installation and treat them appropriately. Methods: for this purpose, medical records of patients admitted to the intensive care unit of Hospital Regional de Ceilândia in the period between 2018 and 2019 without a diagnosis of covid-19 and admissions from 2020 to 2021 who presented the disease were analyzed to identify patients with oral alterations, aiming to compare the prevalence of stomatognathic pathologies between the groups and to correlate the appearance of these alterations to the general condition of the patients. Results: we found a significant frequency of stomatological changes in critically ill patients, with a prevalence of 60.37% of changes in patients without covid 19 and 47.56% in patients with covid-19. Conclusions: in general, the profile of the alterations found were similar
in both samples, the most frequent pathologies were salivary alterations, followed by traumatic injuries and opportunistic infections. The results showed that critically ill patients are susceptible to the development of stomatognathic pathologies during their stay in intensive care, and that patients with covid-19 are more prone to the development of opportunistic infections.
References
1. Marsh PD, Zaura E. Dental biofilm: ecological interactions in health and disease. J Clin Periodontol. 2017;44(Suppl 18):S12-22.
2. Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução RDC nº 7, de 24 de fevereiro de 2010. Dispõe sobre os requisitos mínimos para funcionamento de Unidades de Terapia Intensiva e dá outras providências. Diário Oficial da República Federativa do Brasil, Brasília (DF), 24 fev 2010.
3. Kazemian H, Bourbour S, Beheshti M, Bahador A. Oral colonization by nosocomial pathogens during hospitalization in intensive care unit and prevention strategies. Recent Pat Antiinfect Drug Discov. 2017;12(1):8-20.
4. Bellissimo-Rodrigues W, et al. Effectiveness of a dental care intervention in the prevention of lower respiratory tract nosocomial infections among intensive care patients: a randomized clinical trial. Infect Control Hosp Epidemiol. 2014;35(11):1342-8.
5. Takahama Junior A, et al. Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patients. Clin Oral Investig. 2021;25(3):1217-22.
6. Amorim J, et al. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020;97:326-8.
7. Botros N, Iyer P, Ojcius D. Is there an association between oral health and severity of COVID-19 complications? Biomed J. 2020;43(4):325-7.
8. Xavier A, et al. COVID-19: clinical and laboratory manifestations in novel coronavirus infection. J Bras Patol Med Lab. 2020;56:1-9.
9. Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 2021;97(1147):312-20.
10. Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: a review article. Dermatol Ther. 2020;33(4):e13725.
11. Celik G, Eser I. Examination of intensive care unit patients’ oral health. Int J Nurs Pract. 2017;23(6):e12583.
12. Eduardo FP, et al. Oral lesions and saliva alterations of COVID-19 patients in an intensive care unit: a retrospective study. Spec Care Dentist. 2022;42(5):494-502.
13. Gunes Z, et al. Risk factors affecting dry mouth in inpatients in a hospital in western Anatolia. J Clin Nurs. 2011;21(3-4):408-14.
14. Gonzalez N, et al. Are oral mucosal changes a sign of COVID-19? A cross-sectional study at a field hospital. Actas Dermosifiliogr. 2021;112(7):640-4.
15. Franco J, Cacita N, Freua K, Ortega K, Peres MP. Treatment of drooling with scopolamine in pediatric ICU: a case series report. Spec Care Dentist. 2018;38(6):362-6.
16. Bavikatte G, Sit PL, Hassoon A. Management of drooling of saliva. Br J Med Pract. 2012;5(1):a507.
17. Elluru R. Physiology of the salivary glands. In: Flint PW, Haughey BH, Lund VJ, Niparko JK, Robbins KT, Thomas JR, et al., editors. Cummings Otolaryngology: Head and Neck Surgery. 6th ed. Philadelphia: Elsevier; 2021. p. 1139-48.
18. Farid H, Khan M, Jamal S, Ghafoor R. Oral manifestations of COVID-19: a literature review. Rev Med Virol. 2022;32(1):e2248.
19. Nakajima M, Araki K, Ishikawa A, Yoshida Y, Koseki T. Association between oral candidiasis and bacterial pneumonia: a retrospective study. Oral Dis. 2020;26(1):234-7.
20. Eduardo F, Gobbi M, Bergamin L, Migliorati CA, Bezinelli L. Oral care and photobiomodulation protocol for prevention of traumatic injuries and lip necrosis in critically ill patients with COVID-19: an observational study. Lasers Dent Sci. 2021;5:239-45.
21. Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Wu YC, Sun A. Atrophic glossitis: etiology, serum autoantibodies, anemia, hematinic deficiencies, hyperhomocysteinemia, and management. J Formos Med Assoc. 2020;119(5):774-80.
22. Allen C, Camisa C. Oral disease. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Philadelphia: Elsevier; 2018. p. 1220-42.
23. Mangold A, Torgerson R, Rogers RS. Diseases of the tongue. Clin Dermatol. 2016;34(4):458-69.
24. Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of disease. Am Fam Physician. 2010;82(11):1381-8.
25. James WD, Elston DM, Treat JR, Rosenbach M, Neuhaus IM. Disorders of the mucous membranes. In: James WD, Elston DM, Treat JR, Rosenbach M, Neuhaus IM, editors. Andrews’ Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia: Elsevier; 2020. p. 794-812.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Thaiz Rodrigues Magalhães, Marcos Barbosa Pains
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.
